24 Results

People

  1. Dickler
    Dickler
  2. Morris
    Morris
  3. Motzer
    Motzer
  4. Hudis
    Hudis
  5. Lake
    Lake
  6. O'Reilly
    O'Reilly
  7. Schwartz
    Schwartz
  8. Shah
    Shah
  9. Capanu
    Capanu
  10. Caravelli
    Caravelli

Groups

  1. Department of Medicine (14)
  2. Solid Tumor Oncology Division (13)
  3. Genitourinary Oncology Service (7)
  4. Surgery (4)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (3)
  6. Center for Pancreatic Cancer Research (3)
  7. Gastrointestinal Oncology Service (3)
  8. Biostatistics Service (2)
  9. Body Imaging Service (2)
  10. Breast Medicine Service (2)
  1. "endothelial growth-factor"
Formats
  1. Journal Article (22)
  2. Conference Paper (1)
  3. Review (1)
Groups
  1. Department of Medicine (14)
  2. Solid Tumor Oncology Division (13)
  3. Genitourinary Oncology Service (7)
  4. Surgery (4)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (3)
  6. Center for Pancreatic Cancer Research (3)

More Groups

People
  1. Maura Dickler (3)
  2. Michael Morris (3)
  3. Robert Motzer (3)
  4. Clifford Hudis (2)
  5. Diana Lake (2)
  6. Eileen O'Reilly (2)

More People

Years
  1. 2025 (1)
  2. 2022 (2)
  3. 2020 (1)
  4. 2018 (1)
  5. 2016 (2)
  6. 2015 (3)

More Years

Publications
  1. Journal of Clinical Oncology (7)
  2. Biochemical and Biophysical Research Communications (1)
  3. Blood (1)
  4. Cancer Research (1)
  5. Cancer and Metastasis Reviews (1)
  6. Clinical Cancer Research (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (7)
  2. American Association for Cancer Research (2)
  3. Elsevier Inc. (2)
  4. Elsevier Science, Inc. (2)
  5. American Society of Hematology (1)
  6. American Society of Nephrology (1)

More Publishers

Results (24)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prognostic and predictive analyses of circulating plasma biomarkers in men with metastatic castration resistant prostate cancer treated with docetaxel/prednisone with or without bevacizumab
    Journal Article

    Nixon, A. B.; Liu, Y. M.; Yang, Q.; Luo, B.; Starr, M. D.; Brady, J. C.; Kelly, W. K.; Beltran, H.; Morris, M. J.; George, D. J.; more...
    Prostate Cancer and Prostatic Diseases (2025)

    Fulltext@MSK | Save
  • Personalizing first-line management of metastatic renal cell carcinoma: Leveraging current and novel therapeutic options
    Review

    Fitzgerald, K. N.; Lee, C. H.
    Journal of the National Comprehensive Cancer Network (2022)

    Fulltext@MSK | Save
  • Predictive biomarkers of overall survival in patients with metastatic renal cell carcinoma treated with IFNα ± bevacizumab: Results from CALGB 90206 (alliance)
    Journal Article

    Nixon, A. B.; Halabi, S.; Liu, Y.; Starr, M. D.; Brady, J. C.; Shterev, I.; Luo, B.; Hurwitz, H. I.; Febbo, P. G.; Rini, B. I.; more...
    Clinical Cancer Research (2022)

    Fulltext@MSK | Save
  • Clinical outcomes by nephrectomy status in METEOR, a randomized phase 3 trial of cabozantinib versus everolimus in patients with advanced renal cell carcinoma
    Journal Article

    Tannir, N. M.; Powles, T.; Escudier, B.; Donskov, F.; Grunwald, V.; Sternberg, C. N.; Schmidinger, M.; Schoffski, P.; Szczylik, C.; Peltolta, K.; more...
    Kidney Cancer (2020)

    Fulltext@MSK | Save
  • Investigative strategies on lymphatic vessel modulation for treating lymphedema in future medicine
    Journal Article

    Kataru, R. P.; Mehrara, B. J.; Kim, H.
    Precision and Future Medicine (2018)

    Fulltext@MSK | Save
  • The nephrologist's tumor: Basic biology and management of renal cell carcinoma
    Journal Article

    Hu, S. L.; Chang, A.; Perazella, M. A.; Okusa, M. D.; Jaimes, E. A.; Weiss, R. H.
    Journal of the American Society of Nephrology (2016)

    Fulltext@MSK | Save
  • Phase III trial evaluating letrozole as first-line endocrine therapy with or without bevacizumab for the treatment of postmenopausal women with hormone receptor-positive advanced-stage breast cancer: CALGB 40503 (Alliance)
    Journal Article

    Dickler, M. N.; Barry, W. T.; Cirrincione, C. T.; Ellis, M. J.; Moynahan, M. E.; Innocenti, F.; Hurria, A.; Rugo, H. S.; Lake, D. E.; Hahn, O.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Perivascular M2 macrophages stimulate tumor relapse after chemotherapy
    Journal Article

    Hughes, R.; Qian, B. Z.; Rowan, C.; Muthana, M.; Keklikoglou, I.; Olson, O. C.; Tazzyman, S.; Danson, S.; Addison, C.; Clemons, M.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Genotype correlations with blood pressure and efficacy from a randomized phase III trial of second-line axitinib versus sorafenib in metastatic renal cell carcinoma
    Journal Article

    Escudier, B.; Rini, B. I.; Motzer, R. J.; Tarazi, J.; Kim, S.; Huang, X.; Rosbrook, B.; English, P. A.; Loomis, A. K.; Williams, J. A.
    Clinical Genitourinary Cancer (2015)

    Fulltext@MSK | Save
  • Effective treatment of diverse medulloblastoma models with mebendazole and its impact on tumor angiogenesis
    Journal Article

    Bai, R. Y.; Staedtke, V.; Rudin, C. M.; Bunz, F.; Riggins, G. J.
    Neuro-Oncology (2015)

    Fulltext@MSK | Save